NCT02386826: INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme |
|
|
| Completed | 1 | 65 | US | INC280, INCB28060, bevacizumab, Avastin | SCRI Development Innovations, LLC, Novartis | Glioblastoma Multiforme, Gliosarcoma, Colorectal Cancer, Renal Cell Carcinoma | 07/21 | 08/23 | | |
